- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01441219
Evaluation the Performance of Given Diagnostic System in Detection of Bleeding Events in the Small Bowel
Evaluation the Performance of Given Diagnostic System in Detection of Bleeding Events in the Small Bowel: a Single-arm Prospective Cohort Study.
Obscure gastrointestinal bleeding (OGIB) has been one of the most challenging area in the field of gastroenterology, as small bowel is beyond the reach of ordinary endoscopes like oesophagogastroduodenoscopy (OGD) and colonoscopy. Thanks for the latest technological advancement for investigating small intestine, we are now capable of obtaining intraluminal images safely through capsule endoscopy (CE). Its role in obscure gastrointestinal bleeding, Crohn's disease and other small bowel pathologies has already been proven, and nowadays it is suggested by various authorities to be the first-line modality among all small bowel investigations.
The investigators group has showed that CE can alter the clinical management of patients with OGIB - patients with negative CE has lower rebleeding rate, and therefore we may adopt a conservative approach for them. Although supported by some other group as well, conflicting results were still reported in the literature about the out-come of these patients. The main criticisms for these studies are that, CE can only identify 61% of the underlying small bowel bleeding pathology, and one can never ascertain the outcome of patients with negative CE examination. Apparently there is still room for improvement in the current CE technology.
Studieoversikt
Detaljert beskrivelse
Newer generation of CE (PillCam ColonTM) has been developed to investigate the large bowel. It is different from small bowel CE that it consists of two cameras at both ends of the capsule, so as to enhance the coverage of colonic mucosa visualization. An improved generation of this colon capsule, named PillCam Colon 2TM, is also in its developmental phase. With the new "adaptive frame rate" (AFR) technology, the CE optimizes the visual coverage of the bowel by increasing the frame rate up to 35 frames per second when the capsule is moving quickly in certain areas, while decreasing the frame rate down to 4 frames per second when the capsule is moving slowly or remains stationary so as to conserve the battery life. Preliminary data from colorectal cancer screening has shown that it could improve the diagnostic yield of colonic polyps.
The investigators hypothesize that, by re-programming the PillCam Colon 2TM so as to initiate AFR since ingestion, it could improve the visualization of small intestinal lumen and hence improves the sensitivity of small bowel CE examination.
Studietype
Registrering (Faktiske)
Fase
- Fase 2
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
-
Hong Kong, Kina
- Prince of Wales Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients with overt GI bleeding (hematemesis, coffee-grounds, rectal bleeding and/or melena) with negative OGD but not critically ill, who should read positive on small bowel investigation (SBI)
- Patients with occult GI bleeding (Faecal occult blood test,FOBT +)
- Patients with suspected arteriovenous(AV) malformations.
- Patients treated with nonsteroidal antiinflammatory drugs (NSAIDs)
- Patients with active Crohn's disease(CD), with no evidence of obstruction
Exclusion Criteria:
- In patients with known or suspected gastrointestinal obstruction, strictures, or fistulas based on the clinical picture or pre-ingestion testing and profile.
- In patients with cardiac pacemakers or other implanted electromedical devices.
- In patients with dysphagia or other swallowing disorders.
- Unable to obtain informed written consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Diagnostisk
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Colon 2
using Colon 2 capsule in detecting bleeding events in small bowel
|
Ingest one colon 2 capsule
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Diagnostic yield for bleeding events in the small bowel
Tidsramme: 1 year
|
Review the capsule video to detect the bleeding events.
|
1 year
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Joseph JY Sung, MD, CUHK
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- C2 in SB
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Gastrointestinal blødning
-
AstraZenecaJohnson & Johnson K.K. Medical CompanyFullførtGastrointestinal endoskopi | Gastrointestinal polypektomiJapan
-
University of AarhusMotilis,SwitzerlandFullførtMagetømming | Gastrointestinal motilitet | Total Gastrointestinal Transit Time | Segmentell transporttidDanmark
-
Massachusetts General HospitalPåmelding etter invitasjonGastrointestinal dysfunksjon | Gastrointestinal sykdomForente stater
-
Hospital Universitari Vall d'Hebron Research InstituteInstituto de Salud Carlos IIIRekrutteringGastrointestinal motilitetsforstyrrelseSpania
-
Coconut Goodness Food Products Inc.Aktiv, ikke rekrutterendeGastrointestinal dysfunksjonForente stater
-
Nutricia ResearchFullførtGastrointestinal toleransePolen
-
James J. Peters Veterans Affairs Medical CenterTilbaketrukketGastrointestinal dysfunksjonForente stater
-
Cedars-Sinai Medical CenterUniversity of Michigan; NestléFullført
-
Baylor College of MedicineAlliance for Academic Internal MedicineFullførtEndoskopi, GastrointestinalForente stater
-
Abbott NutritionFullført
Kliniske studier på Colon 2
-
Medtronic - MITGFullført
-
IHU StrasbourgAvsluttet
-
Melbourne HealthMedtronicFullført
-
Medtronic - MITGFullførtCRC-screeningForente stater, Israel
-
Military University Hospital, PragueInstitute for Clinical and Experimental Medicine; Masaryk University; University...Ukjent
-
Groupe d'Etude Therapeutique des Affections Inflammatoires...Aktiv, ikke rekrutterendeCrohns sykdomSpania, Frankrike
-
Medtronic - MITGFullførtKolorektale lesjonerForente stater
-
State Scientific Centre of Coloproctology, Russian...RekrutteringKolorektale neoplasmer, benigneDen russiske føderasjonen
-
Medtronic - MITGFullførtScreening for kolorektal kreftForente stater
-
Medtronic - MITGFullførtKolonsykdommerSpania, Frankrike, Italia, Tyskland, Storbritannia